0.71 USD
↘ 0.22 (23.70%)LIVE (AS OF 03:48 PM EST)
Biofrontera Inc. Common Stock
BFRINASDAQ • USD
Market: OPEN
BFRI is currently priced at $0.71. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". Key drivers include a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, BFRI appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Nov 12, 2026.
Open?$0.96
High?$0.96
Low?$0.69
Prev. Close?$0.93
Volume?844.6K
Avg. Volume?209.4K
VWAP?$0.80
Rel. Volume?4.03x
Bid / Ask
Bid?$0.58 × 100
Ask?$0.81 × 100
Spread?$0.22
Midpoint?$0.70
Valuation & Ratios
Market Cap?13.8M
Shares Out?14.9M
Float?12.8M
Float %?85.9%
P/E Ratio?N/A
P/B Ratio?2.32
EPS?-$0.43
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
Employees
94
Market Cap
13.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-10-29
Address
120 PRESIDENTIAL WAY,
WOBURN, MA 01801
Phone: 781-245-1325
WOBURN, MA 01801
Phone: 781-245-1325
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?0
Momentum?50
Short Sent.?60
Piotroski F-Score?5/9Mixed
Altman Z-Score?-6.18Distress
Confidence?54%Low
Short InterestLow
Short % of Float?1.49%Low
Short Interest?189.6K
Days to Cover?1.3
Free Float12.8M
Avg Daily Volume146.4K
Settlement Date2026-10-30
Financial Health
Current Ratio?1.18Adequate
Quick Ratio?1.08Adequate
Cash Ratio?0.44Low
Debt/Equity?0.78Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.32CHEAP▾
Peers100
S&P68
P/S?0.30CHEAP▾
Peers100
S&P97
P/FCF?N/A▾
EV/EBITDA?-2.2CHEAP▾
S&P97
EV/Sales?0.30CHEAP▾
Peers100
S&P97
Returns & Efficiency
ROE?-106.9%WEAK▾
S&P3
ROA?-26.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-7930000
Enterprise Value?$13.8M
Fundamentals ratios updated end of day